Jennifer Pietenpol Archive — Page 3 of 4

Hand holding a small vaccine vial labeled “1 DOSE VIAL 0.5 mL,” “Quadrivalent Human Papillomavirus Types 6, 11, 16, 18,” “Recombinant Vaccine,” and “GARDASIL,” with a lot number and expiration details visible but too small to read.
January 17, 2017

Vanderbilt-Ingram Cancer Center supports national HPV vaccination efforts

Nearly 39,000 new cancers associated with the human papillomavirus (HPV) will be diagnosed in the United States this year. Although HPV vaccines can prevent the majority of these cancers, vaccination rates remain low across the country.

Elderly man with white hair, glasses, and a white beard wearing a dark suit jacket with a red pocket square, standing beside a red curtain.
December 7, 2016

Vanderbilt mourns loss of philanthropist Tony Martell

Members of the Vanderbilt community are mourning the loss of music executive and health care philanthropist Tony Martell, who died Sunday, Nov. 27, at his home in New Jersey. He was 90.

Strategic-directions graphic with a central compass-style State of the Medical Center 2016 seal, surrounded by four labeled priorities: “Design for Patients and Families,” “Discover, Learn, and Share,” “Make Diversity and Inclusion Intentional,” and “Amplify Innovation.”
December 1, 2016

Basic Science Research Advisory Committee formed

Vanderbilt University School of Medicine (VUSM) has formed a new Basic Science Research Advisory Committee.

Syringe inserted into the bullseye of a black-and-yellow dartboard.
September 9, 2016

In search of new cancer targets

Vanderbilt researchers developed a new algorithm to find clinically targetable gene rearrangements in cancers.

Panel discussion on precision medicine in cancer, with a speaker at a podium and six panelists seated at a table before an audience; a presentation slide with speaker headshots and text is projected above.
May 26, 2016

Precision medicine already changing cancer treatment strategies

The ability to test patients’ cancers for individual differences, mainly at the genetic level, and to make treatment decisions based on those differences is the hallmark of precision medicine, and Vanderbilt University Medical Center (VUMC) is among the leaders of this new approach to diagnosis and treatment.

Portrait of a smiling blonde woman wearing a mustard-yellow jacket in a laboratory setting.
April 14, 2016

Pietenpol named Executive Vice President for Research

Jennifer Pietenpol, Ph.D., director of the Vanderbilt-Ingram Cancer Center, B.F. Byrd Jr. Professor of Molecular Oncology and Professor of Biochemistry, Cancer Biology and Otolaryngology, has been named Executive Vice President for Research at Vanderbilt University Medical Center (VUMC). Her appointment is effective May 1.